MCL1 and hematologic disorder: Overexpression of mitochondrial protein MCL1, a common feature in hematologic malignancies, was associated with venetoclax-resistance in AML VU661013, a selective MCL1 inhibitor able to induce apoptosis in AML cells, overcoming venetoclax resistance [201].